-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported July 30: Annexon Inks $200M Credit Facility Agreement With Oxford Finance

Benzinga·07/31/2026 13:28:00
Listen to the news

Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has entered into a strategic credit facility agreement with Oxford Finance LLC ("Oxford Finance") for up to $200 million.